Research.Patient.info
Active Ulcerative Colitis research hub
2 indexed studies · 1 currently recruiting
- authorisedTherapeutic exploratory (Phase II)
A Phase 2b, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Clinical Study to Evaluate the Efficacy and Safety of ATH-063 Induction Therapy in Patients with Biologic Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
This clinical trial is testing a new capsule treatment called ATH-063 for adults with moderate to severe ulcerative colitis. It is for people whose symptoms have not improved with biologic medicines. Researchers want to see if taking ATH-063 once daily for 12 weeks helps calm bowel inflammation safely.
Poland - recruitingPHASE1
An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
This study is looking at how a new medicine, Afimkibart, affects how your body processes other common medicines in people with active ulcerative colitis. We want to see if it changes how your body uses them.
United States · Belgium · Germany